Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases

The past decade has brought substantial advances in the management of inflammatory bowel diseases (IBD). The introduction of tumor necrosis factor (TNF) antagonists, evidence for the value of combination therapy, the recognition of targeting lymphocyte trafficking and activation as a viable treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinglas, Jason, Gonczi, Lorant, Kurt, Zsuzsanna, Bessissow, Talat, Lakatos, Peter L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113721/
https://www.ncbi.nlm.nih.gov/pubmed/30166855
http://dx.doi.org/10.3748/wjg.v24.i32.3567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113721/
https://www.ncbi.nlm.nih.gov/pubmed/30166855
http://dx.doi.org/10.3748/wjg.v24.i32.3567

Ejemplares similares